Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Antipyretic Drugs For Children Global Market Report 2025
Download Free Sample Buy Now
Global Antipyretic Drugs For Children Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Antipyretic Drugs For Children Global Market Report 2025

By Drug Class (Acetaminophen, Ibuprofen, Other Drug Classes), By Dosage Form (Tablets, Syrups, Suppositories, Other Dosage Forms), By Age Group (Newborns, Infants, Toddlers, Children) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Antipyretic Drugs For Children Market Overview

• Antipyretic Drugs For Children market size has reached to $3.21 billion in 2024

• Expected to grow to $4.34 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%

• Growth Driver: Rising Infections Drive Growth In Antipyretic Drugs For Children

• Market Trend: Innovations in Children's Antipyretic Drugs For Gummy Formulations

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Antipyretic Drugs For Children Market?

Antipyretic drugs for children are medications used to reduce fever in children. They work by lowering the body's temperature through various mechanisms, such as inhibiting the production of fever-inducing substances. These drugs alleviate discomfort and prevent complications associated with high fever in children.

The main drug classes of antipyretic drugs for children are acetaminophen, ibuprofen, and others. Acetaminophen is the alternative name for paracetamol, an analgesic and antipyretic medication for pain relief and fever reduction without anti-inflammatory properties. The various dosage forms include tablets, syrups, suppositories, and others for varying age groups, such as newborns, infants, toddlers, and children.

Antipyretic Drugs For Children Market Size and growth rate 2025 to 2029: Graph

What Is The Antipyretic Drugs For Children Market Size 2025 And Growth Rate?

The antipyretic drugs for children market size has grown strongly in recent years. It will grow from $3.21 billion in 2024 to $3.4 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increasing awareness of pediatric health leading to higher demand for antipyretic medications, growing incidence of fever-related illnesses in children worldwide, rising healthcare expenditures among families to treat common childhood fevers, increasing access to over-the-counter antipyretic drugs in emerging markets and growing emphasis on preventive healthcare and early treatment of pediatric fevers.

What Is The Antipyretic Drugs For Children Market Growth Forecast?

The antipyretic drugs for children market size is expected to see strong growth in the next few years. It will grow to $4.34 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising focus on pediatric healthcare advancements boosting the demand for safer antipyretic drugs, growing prevalence of viral infections in children fueling the need for antipyretic treatments, increasing government initiatives to improve pediatric healthcare access in developing countries, advances in drug formulations and delivery mechanisms enhancing the efficacy of antipyretics and expansion of pharmaceutical companies in emerging markets driving the availability of pediatric medications. Major trends in the forecast period include technological innovations in pediatric drug formulations for faster and safer fever relief, shift towards natural and herbal-based antipyretic drugs for children, increasing focus on personalized pediatric treatments for managing fevers, growing adoption of telemedicine platforms to access pediatric consultations for fever management and development of combination antipyretic drugs targeting multiple symptoms in children.

The forecast of 6.3% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. pediatric practices by driving up costs of acetaminophen and ibuprofen suspensions imported from Canada and Mexico, exacerbating childhood fever management expenses and increasing family healthcare burdens. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Antipyretic Drugs For Children Market Segmented?

1) By Drug Class: Acetaminophen, Ibuprofen, Other Drug Classes

2) By Dosage Form: Tablets, Syrups, Suppositories, Other Dosage Forms

3) By Age Group: Newborns, Infants, Toddlers, Children

Subsegments:

1) By Acetaminophen: Oral Suspension, Chewable Tablets, Suppositories

2) By Ibuprofen: Oral Suspension, Chewable Tablets, Suppositories

3) By Other Drug Classes: Aspirin, Naproxen

What Is Driving The Antipyretic Drugs For Children Market? Rising Infections Drive Growth In Antipyretic Drugs For Children

A growing number of viral and bacterial infections is expected to propel the growth of the antipyretic drugs for children market going forward. Viral infections are caused by viruses, which invade and replicate inside host cells, leading to diseases such as flu (influenza). Bacterial infections result from harmful bacteria entering the body and multiplying, causing illnesses such as strep throat or tuberculosis. The incidence of viral and bacterial infections is increasing due to factors such as growing antibiotic resistance, global travel, and population density, which facilitate the spread of pathogens. Antipyretic drugs, such as acetaminophen or ibuprofen, are used in children to reduce fever and alleviate discomfort caused by viral or bacterial infections. For instance, in May 2022, according to The Office for National Statistics, a UK-based non-ministerial department, between December 2021 and March 2022, there were 6,898 deaths due to flu and pneumonia in the UK, an increase from the 5,288 deaths recorded during the same period in 2020-2021. This reflects a rise of over 1,600 deaths year-over-year. Therefore, the growing number of viral and bacterial infections is driving the growth of the antipyretic drugs for children industry.

What Is Driving The Antipyretic Drugs For Children Market? Growing Birth Rates Drive Demand In The Children's Antipyretic Drug Market

The growing birth rates are expected to propel the growth of the antipyretic drug for children market going forward. Birth rate is the number of live births per 1,000 people in a population per year. A growing birth rate is due to increased access to healthcare, improved economic conditions, and higher fertility rates in certain regions. A growing birth rate can increase the demand for antipyretic drugs for children, as a larger population of infants and young children requires more medical care, including fever management. For instance, in September 2024, according to the Registry of Births, Deaths, and Marriages, Victoria, an Australia-based electronic resource, the number of births registered in Victoria increased from 7,689 in July 2024 to 7,994 in August 2024. Therefore, growing birth rates are driving the antipyretic drug for children market.

Who Are The Major Players In The Global Antipyretic Drugs For Children Market?

Major companies operating in the antipyretic drugs for children market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, GlaxoSmithKline plc, Reckitt Benckiser Group, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Towa Pharmaceutical Co Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Limited

What Are The Key Trends Of The Global Antipyretic Drugs For Children Market? Innovations in Children's Antipyretic Drugs For Gummy Formulations

Major companies operating in the antipyretic drugs for children market are focused on developing advanced drug formulations, such as medicine gummy bites, to enhance ease of administration and improve compliance among young patients. Medicine gummy bites are chewable, gummy-form medications designed to make taking medicine more appealing, especially for children. They come in various forms and flavors to help improve compliance and make the process easier. For instance, in October 2023, DrKids, a US-based pharmaceutical company, launched an acetaminophen gummy bite. It is an innovative medicine offering a child-friendly pain and fever relief alternative. It features an exact dosing system that simplifies medicine administration for parents while ensuring safety and effectiveness.

Need data on a specific region in this market?
Request Regional Data

What Is The Regional Outlook For The Global Antipyretic Drugs For Children Market?

North America was the largest region in the antipyretic drugs for children market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antipyretic drugs for children market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Antipyretic Drugs For Children Market?

The antipyretic drugs for children market consists of sales of acetaminophen (tylenol), ibuprofen (advil, motrin), and naproxen (aleve). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Antipyretic Drugs For Children Industry?

The antipyretic drugs for children market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the antipyretic drugs for children industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Antipyretic Drugs For Children Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $3.4 billion
Revenue Forecast In 2034 $4.34 billion
Growth Rate CAGR of 6.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Class: Acetaminophen, Ibuprofen, Other Drug Classes
2) By Dosage Form: Tablets, Syrups, Suppositories, Other Dosage Forms
3) By Age Group: Newborns, Infants, Toddlers, Children Subsegments: 1) By Acetaminophen: Oral Suspension, Chewable Tablets, Suppositories
2) By Ibuprofen: Oral Suspension, Chewable Tablets, Suppositories
3) By Other Drug Classes: Aspirin, Naproxen
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, GlaxoSmithKline plc, Reckitt Benckiser Group, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Towa Pharmaceutical Co Ltd, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Antipyretic Drugs For Children Market Characteristics

3. Antipyretic Drugs For Children Market Trends And Strategies

4. Antipyretic Drugs For Children Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Antipyretic Drugs For Children Growth Analysis And Strategic Analysis Framework

5.1. Global Antipyretic Drugs For Children PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Antipyretic Drugs For Children Market Growth Rate Analysis

5.4. Global Antipyretic Drugs For Children Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Antipyretic Drugs For Children Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Antipyretic Drugs For Children Total Addressable Market (TAM)

6. Antipyretic Drugs For Children Market Segmentation

6.1. Global Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acetaminophen

Ibuprofen

Other Drug Classes

6.2. Global Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Syrups

Suppositories

Other Dosage Forms

6.3. Global Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Newborns

Infants

Toddlers

Children

6.4. Global Antipyretic Drugs For Children Market, Sub-Segmentation Of Acetaminophen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Suspension

Chewable Tablets

Suppositories

6.5. Global Antipyretic Drugs For Children Market, Sub-Segmentation Of Ibuprofen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Suspension

Chewable Tablets

Suppositories

6.6. Global Antipyretic Drugs For Children Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Aspirin

Naproxen

7. Antipyretic Drugs For Children Market Regional And Country Analysis

7.1. Global Antipyretic Drugs For Children Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Antipyretic Drugs For Children Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antipyretic Drugs For Children Market

8.1. Asia-Pacific Antipyretic Drugs For Children Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antipyretic Drugs For Children Market

9.1. China Antipyretic Drugs For Children Market Overview

9.2. China Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antipyretic Drugs For Children Market

10.1. India Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antipyretic Drugs For Children Market

11.1. Japan Antipyretic Drugs For Children Market Overview

11.2. Japan Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antipyretic Drugs For Children Market

12.1. Australia Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antipyretic Drugs For Children Market

13.1. Indonesia Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antipyretic Drugs For Children Market

14.1. South Korea Antipyretic Drugs For Children Market Overview

14.2. South Korea Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antipyretic Drugs For Children Market

15.1. Western Europe Antipyretic Drugs For Children Market Overview

15.2. Western Europe Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antipyretic Drugs For Children Market

16.1. UK Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antipyretic Drugs For Children Market

17.1. Germany Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antipyretic Drugs For Children Market

18.1. France Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antipyretic Drugs For Children Market

19.1. Italy Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antipyretic Drugs For Children Market

20.1. Spain Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antipyretic Drugs For Children Market

21.1. Eastern Europe Antipyretic Drugs For Children Market Overview

21.2. Eastern Europe Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antipyretic Drugs For Children Market

22.1. Russia Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antipyretic Drugs For Children Market

23.1. North America Antipyretic Drugs For Children Market Overview

23.2. North America Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antipyretic Drugs For Children Market

24.1. USA Antipyretic Drugs For Children Market Overview

24.2. USA Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antipyretic Drugs For Children Market

25.1. Canada Antipyretic Drugs For Children Market Overview

25.2. Canada Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antipyretic Drugs For Children Market

26.1. South America Antipyretic Drugs For Children Market Overview

26.2. South America Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antipyretic Drugs For Children Market

27.1. Brazil Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antipyretic Drugs For Children Market

28.1. Middle East Antipyretic Drugs For Children Market Overview

28.2. Middle East Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antipyretic Drugs For Children Market

29.1. Africa Antipyretic Drugs For Children Market Overview

29.2. Africa Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antipyretic Drugs For Children Market Competitive Landscape And Company Profiles

30.1. Antipyretic Drugs For Children Market Competitive Landscape

30.2. Antipyretic Drugs For Children Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Antipyretic Drugs For Children Market Other Major And Innovative Companies

31.1. Sanofi S.A.

31.2. Bristol Myers Squibb

31.3. GlaxoSmithKline plc

31.4. Reckitt Benckiser Group

31.5. Viatris Inc.

31.6. Teva Pharmaceutical Industries Ltd.

31.7. Sun Pharmaceutical Industries Ltd.

31.8. Perrigo Company plc

31.9. Aurobindo Pharma Ltd.

31.10. Dr. Reddy’s Laboratories Ltd.

31.11. Cipla Ltd.

31.12. Lupin Limited

31.13. Towa Pharmaceutical Co Ltd

31.14. Glenmark Pharmaceuticals Ltd.

31.15. Alkem Laboratories Limited

32. Global Antipyretic Drugs For Children Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antipyretic Drugs For Children Market

34. Recent Developments In The Antipyretic Drugs For Children Market

35. Antipyretic Drugs For Children Market High Potential Countries, Segments and Strategies

35.1 Antipyretic Drugs For Children Market In 2029 - Countries Offering Most New Opportunities

35.2 Antipyretic Drugs For Children Market In 2029 - Segments Offering Most New Opportunities

35.3 Antipyretic Drugs For Children Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Antipyretic Drugs For Children Market, Sub-Segmentation Of Acetaminophen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Antipyretic Drugs For Children Market, Sub-Segmentation Of Ibuprofen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Antipyretic Drugs For Children Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Antipyretic Drugs For Children Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Antipyretic Drugs For Children Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Pfizer Inc. Financial Performance
  • Table 78: Johnson & Johnson Financial Performance
  • Table 79: Merck & Co. Inc. Financial Performance
  • Table 80: Bayer AG Financial Performance
  • Table 81: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Antipyretic Drugs For Children Market, Sub-Segmentation Of Acetaminophen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Antipyretic Drugs For Children Market, Sub-Segmentation Of Ibuprofen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Antipyretic Drugs For Children Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Antipyretic Drugs For Children Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Antipyretic Drugs For Children Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Antipyretic Drugs For Children Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Antipyretic Drugs For Children Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Antipyretic Drugs For Children Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Pfizer Inc. Financial Performance
  • Figure 78: Johnson & Johnson Financial Performance
  • Figure 79: Merck & Co. Inc. Financial Performance
  • Figure 80: Bayer AG Financial Performance
  • Figure 81: Novartis AG Financial Performance

Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Read More About Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

Read More About Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

$8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Read More About $8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

Read More About Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Antiparasitic Drugs Global Market Report 2025 – By Product Type (Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products), By Treatment (Avermectins, Bezimidazoles, Pyrimidines, Organophosphates, Imidazolesthiazo...

View Report

Pediatric Supplements Global Market Report 2025 – By Product Type (Vitamins, Minerals, Probiotics, Omega-3 Fatty Acids, Amino Acids, Other Product Types), By Form (Gummies, Chewable, Liquids, Powders, Tablets, Other Form...

View Report

Antiglaucoma Drugs Market - By Product Type (Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication), By Disease Condition Type (Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Con...

View Report

Anti-Infective Drugs Market - By Type (Antibiotics, Antivirals, Antifungals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classifi...

View Report

Anticoccidial Drugs Global Market Report 2025 – By Drug Class (Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes), By Drug Action (Coccidiostatic, Coccidiocidal), By Application (Poultry, Swin...

View Report

Anticholinergic Drugs Global Market Report 2025 – By Type (Synthetic Compounds, Natural, Semi-Synthetic Compounds), By Route Of Administration (Parental, Oral, Topical), By Application (Overactive Bladder, Parkinson Dise...

View Report

Anti-Parkinson Drugs Global Market Report 2025 – By Drugs Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergi...

View Report

Anti-Infective Drugs Market - By Type (Antibiotics, Antivirals, Antifungals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classifi...

View Report

Frequently Asked Questions

Antipyretic drugs for children are medications used to reduce fever in children. They work by lowering the body's temperature through various mechanisms, such as inhibiting the production of fever-inducing substances. These drugs alleviate discomfort and prevent complications associated with high fever in children. For further insights on this market, request a sample here

The market major growth driver - Rising Infections Drive Growth In Antipyretic Drugs For Children. For further insights on this market, request a sample here

The antipyretic drugs for children market size has grown strongly in recent years. It will grow from $3.21 billion in 2024 to $3.4 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increasing awareness of pediatric health leading to higher demand for antipyretic medications, growing incidence of fever-related illnesses in children worldwide, rising healthcare expenditures among families to treat common childhood fevers, increasing access to over-the-counter antipyretic drugs in emerging markets and growing emphasis on preventive healthcare and early treatment of pediatric fevers. The antipyretic drugs for children market size is expected to see strong growth in the next few years. It will grow to " $4.34 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising focus on pediatric healthcare advancements boosting the demand for safer antipyretic drugs, growing prevalence of viral infections in children fueling the need for antipyretic treatments, increasing government initiatives to improve pediatric healthcare access in developing countries, advances in drug formulations and delivery mechanisms enhancing the efficacy of antipyretics and expansion of pharmaceutical companies in emerging markets driving the availability of pediatric medications. Major trends in the forecast period include technological innovations in pediatric drug formulations for faster and safer fever relief, shift towards natural and herbal-based antipyretic drugs for children, increasing focus on personalized pediatric treatments for managing fevers, growing adoption of telemedicine platforms to access pediatric consultations for fever management and development of combination antipyretic drugs targeting multiple symptoms in children. For further insights on this market, request a sample here

The antipyretic drugs for children market covered in this report is segmented –
1) By Drug Class: Acetaminophen, Ibuprofen, Other Drug Classes
2) By Dosage Form: Tablets, Syrups, Suppositories, Other Dosage Forms
3) By Age Group: Newborns, Infants, Toddlers, Children Subsegments:
1) By Acetaminophen: Oral Suspension, Chewable Tablets, Suppositories
2) By Ibuprofen: Oral Suspension, Chewable Tablets, Suppositories
3) By Other Drug Classes: Aspirin, Naproxen For further insights on this market, request a sample here

North America was the largest region in the antipyretic drugs for children market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipyretic drugs for children market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the antipyretic drugs for children market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, GlaxoSmithKline plc, Reckitt Benckiser Group, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Towa Pharmaceutical Co Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Limited . For further insights on this market, request a sample here.

Major trends in this market include Innovations in Children's Antipyretic Drugs For Gummy Formulations. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Antipyretic Drugs For Children Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon